CAMBRIDGE, United Kingdom

Elisabetta Leo

This inventor holds 1 USPTO granted patent and 8 published patent applications and 2 EPO patents. Top assignee: Astra Zeneca U.k. Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elisabetta Leo. Retrieved from https://idiyas.com/inventor/elisabetta-leo-dbp9tc05

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Elisabetta Leo: Inventor in Biotechnology

Introduction

Elisabetta Leo is an inventor based in Cambridge, United Kingdom. Her patent work includes an invention combining a HER2 antibody-drug conjugate with a selective PARP1 inhibitor.

Latest Patents

Leo is associated with 1 patent: “Combination of Anti-HER2 Antibody-Drug Conjugate and PARP1 Selective Inhibitor.” The invention concerns combining targeted cancer therapy with selective PARP1 inhibition.

Career Highlights

Leo is associated with AstraZeneca UK Limited and AstraZeneca AB. Her patent record reflects work in pharmaceutical research and cancer-treatment innovation.

Collaborations

Her listed collaborators include Jerome Thomas Mettetal and Azadeh Cheraghchi Bashi Astaneh.

Conclusion

Elisabetta Leo’s patent activity highlights her contribution to pharmaceutical innovation, particularly research into combination approaches for cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…